Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-053033
Filing Date
2025-04-11
Accepted
2025-04-11 08:00:37
Documents
4
Period of Report
2025-05-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A snse-def-proxy-fy2024_no.htm DEF 14A 1007390
2 GRAPHIC img76909286_0.jpg GRAPHIC 96722
3 GRAPHIC img76909286_1.jpg GRAPHIC 2130705
4 GRAPHIC img76909286_2.jpg GRAPHIC 382878
  Complete submission text file 0000950170-25-053033.txt   4596196
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39980 | Film No.: 25829900
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)